BioSpace News Archive

Children’s National Research Institute (CNRI), the research arm of the nation’s No. 6 ranked children’s hospital is rolling out the TriNetX platform to investigators at Children’s National Hospital and taking the lead in establishing a research collaborative among pediatric hospitals within TriNetX’s global health research network.

Ligand Pharmaceuticals Incorporated announced plans to report third quarter 2019 financial results on November 5, 2019.

Nobel laureates and world-leading thinkers to discuss health and wellbeing at free-of-charge event titled ‘Towards Health’ on Nov. 8

Veracyte, Inc. announced financial results and business progress for the third quarter ended September 30, 2019.

Halloween is upon us! Pumpkin patches, haunted houses and trick-or-treating are fun and festive ways to celebrate this holiday, but the excitement of these activities can quickly turn dangerous if you’re not careful.

BioAegis Therapeutics was recently recognized by PitchBook as the most valuable venture-backed company in New Jersey led by a female entrepreneur.

AptarGroup, Inc. announced that its Activ-Blister™ packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration for a HIV prevention medicine..

Late-breaking data presented from a Phase 2a trial at UEG Week 2019, Barcelona, Spain, highlights potential of investigational medicine to prevent gluten induced immune activation in patients with celiac disease

PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPAC™ micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board..

Multiple ascending dose study will assess the safety and efficacy of ASLAN004 in patients with moderate to severe atopic dermatitis